Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Amgen inc.    crawled date : 2021 - 10 - 07    save search

Amgen Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK 101 Study In Patients With KRAS G12C-mutated Cancers At AACR-NCI-EORTC 2021
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
BGNE | $131.94 0.06% 0.06% 130K twitter stocktwits trandingview |
Health Technology
| | O: 1.77% H: 4.53% C: 4.35%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 1.88% C: 0.28%

phase 1 cancer phase 1b phase 2b
Worldwide Orphan Drugs Industry to 2027 - Featuring Jazz Pharmaceuticals, Merck & Co and Pfizer Among Others
Published: 2021-10-07 (Crawled : 22:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380 twitter stocktwits trandingview |
Health Technology
| | O: 3.76% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.17% C: -0.7%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.0% C: 0.0%
BMY | $48.3 0.96% -0.1% 11M twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.2% C: -2.73%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.0% C: 0.0%
JAZZ | $109.3 2.05% 2.01% 560K twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 1.01% C: -1.78%
BIIB | $190.55 -0.84% -0.84% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.54% C: -0.56%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.0% C: 0.0%

orphan drug drug
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
BGNE | $131.94 0.06% 0.06% 130K twitter stocktwits trandingview |
Health Technology
| | O: 1.77% H: 4.53% C: 4.35%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 1.88% C: 0.28%

disease collaboration therapy train
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.